Administration of Interferon (IFN)-α Exacerbates Reovirus Type-2-Triggered Autoimmune Insulitis in DBA/1J Mice

Scandinavian Journal of Immunology

Volumn 76, Issue 4, 2012, Pages 378-386

  Nakashima, T ^a   Hayashi, T ^a   Yamamoto, Y ^a   Mizuno, T ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GLUCOSE; MESSENGER RNA; VIRUS ANTIGEN;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE INSULITIS; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HISTOLOGY; IMPAIRED GLUCOSE TOLERANCE; INSULITIS; INTERFERON PRODUCTION; MAMMALIAN ORTHOREOVIRUS; MOUSE; NEWBORN; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; THYMUS; VIROGENESIS; VIRUS TITRATION;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, VIRAL; AUTOIMMUNE DISEASES; BLOOD GLUCOSE; CELL MOVEMENT; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN; INTERFERON-ALPHA; ISLETS OF LANGERHANS; MICE; MICE, INBRED DBA; ORTHOREOVIRUS, MAMMALIAN; RECOMBINANT PROTEINS; REOVIRIDAE INFECTIONS; SPLEEN; THYMUS GLAND; TIME FACTORS;

EID: 84866280766     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02754.x     Document Type: Article

References (43)

1. Unger RH, Foster DW. Diabetes mellitus. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology, 7th edn. Philadelphia, PA: WB Saunders, 1985:1018-80. ISBN: 072161082X.
2. Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Br Med J 1973;4:260-2.
3. Lammi N, Karvonen M, Tuomilehto J. Do microbes have a causal role in type 1 diabetes? Med Sci Monit 2005;11:RA63-9.
4. Rosu V, Ahmed N, Paccagnini D et al. Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberuclosis with type-1 but not type-2 diabetes mellitus. PLoS One 2009;4:e4386.
5. Dobersen MJ, Scharff JE, Ginsberg-Fellner F, Notkins AL. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 1980;303:1493-8.
6. Maruyama T, Takei I, Asaba Y et al. Insulin autoantibodies in mouse models of insulin-dependent diabetes. Diabetes Res 1989;11:61-5.
7. Hayashi T, Yoshinaka K, Hasegawa K, Maeda K, Onodera T. CpG oligodeoxynucleotides accelerate reovirus type 2-triggered insulitis in DBA/1 suckling mice. Int J Exp Pathol 2002;83:217-23.
8. + regulatory T cells breaks down reovirus type 2-triggered and CpG ODN-induced prolonged mild autoimmune insulitis in DBA/1 mice. Scand J Immunol 2006;63:116-24.
9. Schiff LA, Nibert ML, Tyler KL. Orthoreoviruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology, 5th edn, Vol. 2. Philadelphia, PA: Lippincott Williams and Wilkins, 2007:1853-915. ISBN: 9780781760607.
10. Selb B, Webr B. A study of human Reovirus IgG and IgA antibodies by ELISA and Western blot. J Virol Methods 1994;47:15-26.
11. Fields BN, Greene MI. Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature 1982;300:19-23.
12. Hayashi T, Yasutomi Y, Hasegawa K, Sasaki Y, Onodera T. Interleukin-4-expressing plasmid DNA inhibits reovirus type-2-triggered autoimmune insulitis in DBA/1J suckling mice. Int J Exp Pathol 2003;84:101-6.
13. Kadowaki N, Liu YJ. Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum Immunol 2002;63:1126-32.
14. Nash AA. Section 3, Chapter 13: Immunity to viruses. In: Male D, Brostoff J, Roth DB, Roitt I, eds. Immunology, 7th edn, Philadelphia, PA: Mosby Elsevier, 2006:247-56. ISBN: 9780323033992.
15. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006;25:383-92.
16. Rönnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006;54:408-20.
17. Hooks JJ, Moutsopoulos HM, Geis SA et al. Immune interferon in the circulation of patients with autoimmune diseases. N Engl J Med 1979;301:5-8.
18. Foulis AK, Farquharson MA, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987;2:1423-7.
19. Stewart TA, Hultgren B, Huang X et al. Induction of type I diabetes by interferon-α in transgenic mice. Science 1993;260:1942-6.
20. Huang X, Yuang J, Goddard A et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995;44:658-64.
21. Alba A, Puertas MC, Carrillo J et al. IFNβ accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice. J Immunol 2004;173:6667-75.
22. Li Q, Xu B, Michie SA et al. Interferon-α initiates type 1 diabetes in nonobese diabetic mice. Proc Nati Acad Sci USA 2008;105:12439-44.
23. Kurogi H, Inaba Y, Takahashi E, Sato K, Omori T. Serological relationship between Japanese strains of Reovirus of bovine origin and type 2 reovirus strains. Natl Inst Anim Health Q 1980;20:32-3.
24. Hayashi T, Iwata H, Onodera T. Role of interleukin-2 in pancreatic islet-cell destruction in reovirus type 2-infected DBA/1 suckling mice. J Comp Pathol 1999;120:313-20.
25. Onodera T, Taniguchi T, Yoshihara K et al. Reovirus type 2-induced diabetes in mice prevented by immunosuppression and thymic hormone. Diabetologia 1990;33:192-6.
26. Hayashi T, Morimoto M, Iwata H, Onodera T. Interferon-gamma plays a role in pancreatic islet-cell destruction of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice. Int J Exp Pathol 1998;79:313-20.
27. Tailor P, Tamura T, Kong HJ et al. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007;27:228-39.
28. Male D, Brostoff J, Roth DB, Roitt I. Appendices, 3. The major cytokines. In: Male D, Brostoff J, Roth DB, Roitt I, eds. Immunology, 7th edn. Philadelphia, PA: Mosby Elsevier, 2006:522-3. ISBN: 9780323033992.
29. Onodera T, Taniguchi T, Tsuda T et al. Thymic atrophy in type 2 reovirus infected mice: immunosuppression and effects of thymic hormone. Thymic atrophy caused by reo-2. Thymus 1991;18:95-109.
30. Ittah M, Miceli-Richard C, Gottenberg JE et al. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. Eur J Immunol 2008;38:1058-64.
31. Ittah M, Miceli-Richard C, Gottenberg JE et al. B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation. Eur J Immunol 2009;39:1271-9.
32. Edelmann KH, Richardson-Burns S, Alexopoulou L et al. Does Toll-like receptor 3 play a biological role in virus infections? Virology 2004;322:231-8.
33. Hayashi T, Morimoto M, Iwata H, Onodera T. Possible involvement of IL-12 in Reovirus type-2-induced diabetes in newborn DBA/1 mice. Scand J Immunol 2001;53:572-8.
34. Bonnevie-Nielsen V, Buschard K, Dyrberg T. Differential responsiveness to interferon-alpha in beta-cells and non-beta cells. Diabetes 1996;45:818-21.
35. Bonnevie-Nielsen V, Gerdes AM, Fleckner J et al. Interferon stimulates the expression of 2′, 5′-oligoadenylate synthetase and MHC class I antigens in insulin-producing cells. J Interferon Res 1991;11:255-60.
36. Ewel CH, Sobel DO, Zeligs BJ, Bellanti JA. Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 1992;41:1016-21.
37. Sobel DO, Ewel CH, Zeligs B et al. Poly I:C induction of alpha-interferon in the diabetes-prone BB and normal Wister rats. Dose-response relationship. Diabetes 1994;43:518-22.
38. Carpenter DF, Steinberg AD, Schur PH, Talal N. The pathogenesis of autoimmunity in New Zealand mice. II. Acceleration of glomerulonephritis by polyinosinic-polycytidylic acid. Lab Invest 1970;23:628-34.
39. Adam C, Thoua Y, Ronco P et al. The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) mice. Clin Exp Immunol 1980;40:373-82.
40. De Clercp E. Interferon induction by polynucleotide, modified polynucleotides, and polycarboxylates. Methods Enzymol 1981;78:227-36.
41. Krug A, Rothenfusser S, Hornung V et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001;31:2154-63.
42. Pay S, Pekel A, Simsek I et al. Pronounced interferon-alpha production from plasmacytoid dendritic cells in patients with Behcet's disease following CpG D ODN stimulation. Clin Exp Rheumatol 2009;27:S37-42.
43. Schattner A. Interferons and autoimmunity. Am J Med Sci 1988;295:532-44.